The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome
- PMID: 9455826
- DOI: 10.1093/humrep/12.12.2629
The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome
Abstract
This review examines recent evidence suggesting a role for the immune system, in particular cytokines, in the pathogenesis of ovarian hyperstimulation syndrome (OHSS). Ovarian tissue is known to contain cells capable of producing a range of immunological mediators and the concentrations of these have been shown to be elevated in serum and ascitic fluid from women with established OHSS. Available evidence points to a role for vascular endothelial growth factor and interleukin-2, possibly acting through other intermediary cytokines, in the pathogenesis of OHSS. However, each individual has a unique cytokine profile and several cytokines may share biological actions, making it difficult to interpret data on isolated cytokine concentrations from relatively small numbers of patients. Improved understanding of the role of the immune system in the development of OHSS may have implications for the prediction, prevention and management of this iatrogenic condition.
Similar articles
-
Ovarian hyperstimulation syndrome: a new insight into an old enigma.J Soc Gynecol Investig. 1998 May-Jun;5(3):110-3. doi: 10.1016/s1071-5576(97)00113-5. J Soc Gynecol Investig. 1998. PMID: 9614638 Review.
-
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.Hum Reprod Update. 1997 May-Jun;3(3):255-66. doi: 10.1093/humupd/3.3.255. Hum Reprod Update. 1997. PMID: 9322101 Review.
-
The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.Fertil Steril. 1999 Mar;71(3):482-9. doi: 10.1016/s0015-0282(98)00484-1. Fertil Steril. 1999. PMID: 10065786 Clinical Trial.
-
Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.Eur J Obstet Gynecol Reprod Biol. 1999 Nov;87(1):81-5. doi: 10.1016/s0301-2115(99)00082-2. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10579621
-
Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome.Fertil Steril. 1999 Aug;72(2):286-92. doi: 10.1016/s0015-0282(99)00206-x. Fertil Steril. 1999. PMID: 10438997
Cited by
-
Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome.BMC Pregnancy Childbirth. 2020 Nov 12;20(1):691. doi: 10.1186/s12884-020-03379-9. BMC Pregnancy Childbirth. 2020. PMID: 33183268 Free PMC article.
-
Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial.J Ovarian Res. 2025 May 29;18(1):113. doi: 10.1186/s13048-025-01702-6. J Ovarian Res. 2025. PMID: 40442814 Free PMC article. Clinical Trial.
-
Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS).J Ovarian Res. 2020 Mar 5;13(1):25. doi: 10.1186/s13048-020-00624-9. J Ovarian Res. 2020. PMID: 32138790 Free PMC article.
-
Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome--a preliminary proof of concept.J Ovarian Res. 2014 Nov 26;7:106. doi: 10.1186/s13048-014-0106-2. J Ovarian Res. 2014. PMID: 25424734 Free PMC article.
-
Immunological link between primary graft dysfunction and chronic lung allograft rejection.Ann Thorac Surg. 2008 Jul;86(1):189-95; discussion 196-7. doi: 10.1016/j.athoracsur.2008.03.073. Ann Thorac Surg. 2008. PMID: 18573422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources